Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rangnekar

Showing results (111-120 of 267) with videos related to

Pageof 27
Sort By:
Cell|July 28, 2009
The tumor suppressor Par-4 activates an extrinsic pathway for apoptosisRavshan Burikhanov, Yanming Zhao, Anindya Goswami, et al.
Human Genetics|August 1, 1992
Crossed renal ectopia with pelvic lipomatosis: a new syndrome involving chromosome 1H K Goswami, G V Rangnekar, S Varshney, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 20, 2013
Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patientsAmol S Rangnekar, Caitlyn Ellerbe, Valerie Durkalski, et al.
Biotechnology Journal|September 12, 2012
An autonomously self-assembling dendritic DNA nanostructure for target DNA detectionHarish Chandran, Abhijit Rangnekar, Geetha Shetty, et al.
International Journal of Health Policy and Management|February 16, 2021
Towards Core Competencies for Health Policy and Systems Research (HPSR) Training: Results From a Global Mapping and Consensus-Building ProcessMeike J Schleiff, Avanti Rangnekar, Francisco Oviedo Gomez, et al.
Oncogene|February 16, 1999
Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4G Qiu, M Ahmed, S F Sells, et al.
Central Asian Journal of Global Health|July 20, 2019
Sero-Occurrence of HBV/HCV Co-infection and Levels of Liver Enzymes among Patients at a Tertiary Care Hospital in Central India: a Pilot StudyPrabha Desikan, Aseem Rangnekar, Zeba Khan, et al.
ACG Case Reports Journal|January 1, 2025
Atorvastatin-Induced Liver Injury With Concurrent Rhabdomyolysis After a Positive RechallengeHarjit Singh, Adam Khalaf, Bryce F Kunkle, et al.
Pharmaceutical Research|April 23, 2008
Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM)Asfar Sohail Azmi, Aamir Ahmad, Sanjeev Banerjee, et al.
Cancer Research|August 5, 2008
Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activityAnindya Goswami, Shirley Qiu, Thomas S Dexheimer, et al.
Pageof 27

Showing results (111-120 of 267) with videos related to

Sort By:
Pageof 27
Cell|July 28, 2009
The tumor suppressor Par-4 activates an extrinsic pathway for apoptosisRavshan Burikhanov, Yanming Zhao, Anindya Goswami, et al.
Human Genetics|August 1, 1992
Crossed renal ectopia with pelvic lipomatosis: a new syndrome involving chromosome 1H K Goswami, G V Rangnekar, S Varshney, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 20, 2013
Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patientsAmol S Rangnekar, Caitlyn Ellerbe, Valerie Durkalski, et al.
Biotechnology Journal|September 12, 2012
An autonomously self-assembling dendritic DNA nanostructure for target DNA detectionHarish Chandran, Abhijit Rangnekar, Geetha Shetty, et al.
International Journal of Health Policy and Management|February 16, 2021
Towards Core Competencies for Health Policy and Systems Research (HPSR) Training: Results From a Global Mapping and Consensus-Building ProcessMeike J Schleiff, Avanti Rangnekar, Francisco Oviedo Gomez, et al.
Oncogene|February 16, 1999
Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4G Qiu, M Ahmed, S F Sells, et al.
Central Asian Journal of Global Health|July 20, 2019
Sero-Occurrence of HBV/HCV Co-infection and Levels of Liver Enzymes among Patients at a Tertiary Care Hospital in Central India: a Pilot StudyPrabha Desikan, Aseem Rangnekar, Zeba Khan, et al.
ACG Case Reports Journal|January 1, 2025
Atorvastatin-Induced Liver Injury With Concurrent Rhabdomyolysis After a Positive RechallengeHarjit Singh, Adam Khalaf, Bryce F Kunkle, et al.
Pharmaceutical Research|April 23, 2008
Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM)Asfar Sohail Azmi, Aamir Ahmad, Sanjeev Banerjee, et al.
Cancer Research|August 5, 2008
Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activityAnindya Goswami, Shirley Qiu, Thomas S Dexheimer, et al.
Pageof 27